Lishan Aklog
CIK 1665074 · Chairman and CEO · last filed 2026-04-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PAVMZ price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 300
NEW YORK, NY 10171
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PAVM | Chairman and CEO | 367,518 | $2.26 | $830.6K | $0 | 2 | 2026-04-03 |
| LUCD | Chief Executive Officer | 3,636,627 | $0.54 | $1.95M | $0 | 5 | 2026-02-24 |
| CONTRAFECT Corp (CFRX) Delisted | Director | — | $0.05 | — | $0 | 3 | 2022-05-18 |
| PAVmed Inc. (PAVMZ) Delisted | Chairman and CEO | 178,557 | $0.00 | $161 | $201.1K | 7 | 2022-04-11 |
| Viveon Health Acquisition Corp. (VHAQ.U) Delisted | Director | 27,000 | $11.20 | $302.4K | $0 | 1 | 2020-12-28 |
| PAVmed Inc. (PAVMW) Delisted | Chairman and CEO | 5,783,218 | $0.03 | $167.7K | $128.4K | 9 | 2017-11-21 |
| PAVmed Inc. (PAVM.U) Delisted | Chairman and CEO | 92,120 | — | — | $0 | 2 | 2016-05-23 |
Recent Filings · Page 3 of 3
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-09-11 | PAVmed Inc. (PAVMW) Delisted | Buy (P) | +3,750 | $0 | EDGAR |
| 2017-09-05 | PAVmed Inc. (PAVMW) Delisted | Buy (P) | +10,836 | $0 | EDGAR |
| 2017-08-25 | PAVmed Inc. (PAVMW) Delisted | Buy (P) | +27,300 | $0 | EDGAR |
| 2017-08-21 | PAVmed Inc. (PAVMW) Delisted | Buy (P) | +30,600 | $0 | EDGAR |
| 2017-01-12 | PAVmed Inc. (PAVMW) Delisted | Buy (P) | — | $0 | EDGAR |
| 2016-11-28 | PAVmed Inc. (PAVMW) Delisted | Buy (P) | +6,600 | $59.3K | EDGAR |
| 2016-11-22 | PAVmed Inc. (PAVMW) Delisted | Buy (P) | +6,900 | $69.1K | EDGAR |
| 2016-05-23 | PAVmed Inc. (PAVM.U) Delisted | Buy (P) | +9,300 | $0 | EDGAR |
| 2016-05-02 | PAVmed Inc. (PAVM.U) Delisted | Grant (A) | +732,060 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.